These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7687536)

  • 1. Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.
    Noble ME; Musacchio A; Saraste M; Courtneidge SA; Wierenga RK
    EMBO J; 1993 Jul; 12(7):2617-24. PubMed ID: 7687536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a Src-homology 3 (SH3) domain.
    Musacchio A; Noble M; Pauptit R; Wierenga R; Saraste M
    Nature; 1992 Oct; 359(6398):851-5. PubMed ID: 1279434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
    Arold S; Franken P; Strub MP; Hoh F; Benichou S; Benarous R; Dumas C
    Structure; 1997 Oct; 5(10):1361-72. PubMed ID: 9351809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of human CskSH3: structural diversity near the RT-Src and n-Src loop.
    Borchert TV; Mathieu M; Zeelen JP; Courtneidge SA; Wierenga RK
    FEBS Lett; 1994 Mar; 341(1):79-85. PubMed ID: 7511113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
    Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
    J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure and peptide binding of the SH3 domain from human Fyn.
    Morton CJ; Pugh DJ; Brown EL; Kahmann JD; Renzoni DA; Campbell ID
    Structure; 1996 Jun; 4(6):705-14. PubMed ID: 8805554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor.
    Qiu X; Pohl E; Holmes RK; Hol WG
    Biochemistry; 1996 Sep; 35(38):12292-302. PubMed ID: 8823163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains.
    Weng Z; Thomas SM; Rickles RJ; Taylor JA; Brauer AW; Seidel-Dugan C; Michael WM; Dreyfuss G; Brugge JS
    Mol Cell Biol; 1994 Jul; 14(7):4509-21. PubMed ID: 7516469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.
    Fernandez-Ballester G; Blanes-Mira C; Serrano L
    J Mol Biol; 2004 Jan; 335(2):619-29. PubMed ID: 14672668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.
    Rickles RJ; Botfield MC; Weng Z; Taylor JA; Green OM; Brugge JS; Zoller MJ
    EMBO J; 1994 Dec; 13(23):5598-604. PubMed ID: 7988556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An SH2-SH3 domain hybrid.
    Russell RB; Barton GJ
    Nature; 1993 Aug; 364(6440):765. PubMed ID: 7689175
    [No Abstract]   [Full Text] [Related]  

  • 14. Structures of Src-family tyrosine kinases.
    Sicheri F; Kuriyan J
    Curr Opin Struct Biol; 1997 Dec; 7(6):777-85. PubMed ID: 9434895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions.
    Erpel T; Superti-Furga G; Courtneidge SA
    EMBO J; 1995 Mar; 14(5):963-75. PubMed ID: 7534229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
    Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
    Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton.
    Ziemnicka-Kotula D; Xu J; Gu H; Potempska A; Kim KS; Jenkins EC; Trenkner E; Kotula L
    J Biol Chem; 1998 May; 273(22):13681-92. PubMed ID: 9593709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein.
    Reedquist KA; Fukazawa T; Druker B; Panchamoorthy G; Shoelson SE; Band H
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4135-9. PubMed ID: 7514295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
    Espino PC; Chou WY; Smith AE; Cheng SH
    Oncogene; 1992 Feb; 7(2):317-22. PubMed ID: 1372400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.